Clinical Trial Update: SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing SHR-A1811 to investigator's chemotherapy in recurrent/metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING